Drugs Made In America Acquisition (DMAA) Stock Chart & Stock Price History $10.30 +0.01 (+0.10%) As of 10/21/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Drugs Made In America Acquisition Stock Price Performance The Drugs Made In America Acquisition (DMAA) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Drugs Made In America Acquisition traded at $10.30 with a market cap of $300.46 million and volume of 4,548 shares. Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance0.00% DMAA Stock Chart for Wednesday, October, 22, 2025 DMAA Chart by TradingView Drugs Made In America Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/21/2025$10.29$10.30+0.10%$10.33$10.304,548 shs$300.46 million10/20/2025$10.30$10.29-0.10%$10.32$10.294,934 shs$300.16 million10/17/2025$10.31$10.30-0.10%$10.30$10.30482 shs$300.45 million10/16/2025$10.30$10.31+0.10%$10.31$10.3024,352 shs$300.74 million10/15/2025$10.30$10.30$10.31$10.303,308 shs$300.46 million10/14/2025$10.30$10.30$10.31$10.2852,512 shs$300.45 million10/13/2025$10.29$10.30+0.10%$10.30$10.292,852 shs$300.45 million10/10/2025$10.28$10.29+0.10%$10.34$10.264,296 shs$300.16 million10/09/2025$10.30$10.28-0.19%$10.33$10.285,906 shs$299.88 million10/08/2025$10.30$10.30$10.32$10.28308,387 shs$300.45 million Get the Latest News and Ratings for DMAA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. 10/07/2025$10.27$10.30+0.29%$10.31$10.2892,226 shs$300.45 million10/06/2025$10.27$10.27$10.27$10.271,455 shs$299.59 million10/03/2025$10.27$10.27$10.27$10.2710,135 shs$299.59 million10/02/2025$10.26$10.27+0.10%$10.27$10.27119 shs$299.58 million10/01/2025$10.27$10.26-0.10%$10.27$10.265,033 shs$299.28 million09/30/2025$10.27$10.27$10.28$10.265,057 shs$299.59 million09/29/2025$10.28$10.27-0.10%$10.28$10.2684,201 shs$299.58 million09/26/2025$10.28$10.28$10.28$10.264,515 shs$299.87 million09/25/2025$10.31$10.28-0.29%$10.30$10.26159,001 shs$299.87 million09/24/2025$10.26$10.31+0.49%$10.34$10.28545,562 shs$300.75 million09/23/2025$10.30$10.26-0.39%$10.27$10.26211 shs$299.28 million09/22/2025$10.28$10.30+0.19%$10.30$10.26864 shs$300.45 million Related Companies SAFE Stock Price Chart ORC Stock Price Chart IPXX Stock Price Chart DEA Stock Price Chart CSR Stock Price Chart SBR Stock Price Chart GETY Stock Price Chart PLYM Stock Price Chart PAX Stock Price Chart FBRT Stock Price Chart Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAA) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
